IL188691A0 - Compositions and methods to control angiogenesis with cupredoxins - Google Patents
Compositions and methods to control angiogenesis with cupredoxinsInfo
- Publication number
- IL188691A0 IL188691A0 IL188691A IL18869108A IL188691A0 IL 188691 A0 IL188691 A0 IL 188691A0 IL 188691 A IL188691 A IL 188691A IL 18869108 A IL18869108 A IL 18869108A IL 188691 A0 IL188691 A0 IL 188691A0
- Authority
- IL
- Israel
- Prior art keywords
- cupredoxins
- compositions
- methods
- control angiogenesis
- angiogenesis
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70029705P | 2005-07-19 | 2005-07-19 | |
| US11/244,105 US7691383B2 (en) | 2004-10-07 | 2005-10-06 | Cupredoxin derived transport agents and methods of use thereof |
| US76474906P | 2006-02-03 | 2006-02-03 | |
| US11/436,592 US7381701B2 (en) | 2001-02-15 | 2006-05-19 | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| PCT/US2006/027940 WO2007024368A2 (en) | 2005-07-19 | 2006-07-19 | Compositions and methods to control angiogenesis with cupredoxins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL188691A0 true IL188691A0 (en) | 2008-08-07 |
Family
ID=37772089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL188691A IL188691A0 (en) | 2005-07-19 | 2008-01-09 | Compositions and methods to control angiogenesis with cupredoxins |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1904081A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009502797A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080034905A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006284490A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0615555A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2615560A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL188691A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008000993A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20080829L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007024368A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8158574B2 (en) * | 2004-10-07 | 2012-04-17 | Cdg Therapeutics, Inc. | Compositions and methods to prevent cancer with cupredoxins |
| EP2061498A4 (en) * | 2006-09-14 | 2009-11-04 | Univ Illinois | COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES |
| AU2007329375A1 (en) | 2006-12-04 | 2008-06-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
| UA97466C2 (ru) * | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Транспортирующие соединения - производные купредоксина и способы их применения |
| AU2006277009A1 (en) * | 2005-05-20 | 2007-02-15 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| JP2008545398A (ja) * | 2005-05-20 | 2008-12-18 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | キュプレドキシンおよびシトクロムcを用いてhiv感染を治療するための組成物および方法 |
| AU2006251742A1 (en) * | 2005-05-20 | 2006-11-30 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating malaria with cupredoxin and cytochrome |
-
2006
- 2006-07-19 WO PCT/US2006/027940 patent/WO2007024368A2/en not_active Ceased
- 2006-07-19 AU AU2006284490A patent/AU2006284490A1/en not_active Abandoned
- 2006-07-19 BR BRPI0615555-3A patent/BRPI0615555A2/pt not_active IP Right Cessation
- 2006-07-19 MX MX2008000993A patent/MX2008000993A/es active IP Right Grant
- 2006-07-19 CA CA002615560A patent/CA2615560A1/en not_active Abandoned
- 2006-07-19 EP EP06787787A patent/EP1904081A4/en not_active Withdrawn
- 2006-07-19 JP JP2008522911A patent/JP2009502797A/ja active Pending
- 2006-07-19 KR KR1020087002477A patent/KR20080034905A/ko not_active Ceased
-
2008
- 2008-01-09 IL IL188691A patent/IL188691A0/en unknown
- 2008-02-15 NO NO20080829A patent/NO20080829L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007024368A3 (en) | 2007-10-11 |
| WO2007024368A2 (en) | 2007-03-01 |
| AU2006284490A8 (en) | 2008-02-28 |
| KR20080034905A (ko) | 2008-04-22 |
| NO20080829L (no) | 2008-04-02 |
| EP1904081A4 (en) | 2008-12-03 |
| EP1904081A2 (en) | 2008-04-02 |
| CA2615560A1 (en) | 2007-03-01 |
| AU2006284490A1 (en) | 2007-03-01 |
| BRPI0615555A2 (pt) | 2009-07-14 |
| MX2008000993A (es) | 2008-03-19 |
| JP2009502797A (ja) | 2009-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2469243B (en) | Improvements in or relating to ablutionary installations | |
| PH12008501163B1 (en) | Shading composition | |
| IL197602A0 (en) | Compositions and methods to prevent cancer with cupredoxins | |
| ZA200901077B (en) | Sunscreen composition | |
| ZA201001305B (en) | Pyrone analog compositions and methods | |
| ZA200802220B (en) | Improvements in or relating to compositions | |
| GB0622399D0 (en) | Novel compositions and uses thereof | |
| GB0617171D0 (en) | Novel compositions and methods | |
| ZA200800503B (en) | Compositions and methods to control angiogenesis with cupredoxins | |
| GB0519717D0 (en) | Improvements in or relating to devices | |
| TWI367094B (en) | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands | |
| GB2425531B (en) | Cement compositions with aplite | |
| EP1889173A4 (en) | SUBSCRIPTION OF CONTENT | |
| GB0520931D0 (en) | Improvements in or relating to compositions | |
| GB0601036D0 (en) | Improvements in or related to organic compositions | |
| AU2006284490A8 (en) | Compositions and methods to control angiogenesis with cupredoxins | |
| GB0709868D0 (en) | Improvements in or relating to buildings | |
| EP2010141A4 (en) | NUCLEOTIDE COMPOSITIONS HAVING HIGH DEPOSITS AND USES THEREOF | |
| GB0622400D0 (en) | Novel compositions and uses thereof | |
| GB0500224D0 (en) | Improvements in or relating to ablutionary installations | |
| GB0600336D0 (en) | Composition and uses thereof | |
| GB0614252D0 (en) | Improvements to building elements | |
| GB0504185D0 (en) | Improved glazing composition and uses thereof | |
| GB0500847D0 (en) | Claims to be made | |
| GB0517718D0 (en) | Further improvement to brikmat |